American Benefits Council: Increased Price Transparency Has Potential to Lower Health Care Costs, Increase Value for Consumers
In written comments filed on
The Council's letter emphasizes the critical role that employers play in the health care system, leveraging purchasing power, market efficiencies and plan design innovations to provide health coverage to over 178 million Americans. The Council asserts that "employer plan sponsors can use transparent price and quality information to develop innovative plan designs that steer patients towards higher-value health care providers." As such, "greater price and quality transparency in health care is an area of critical importance for employer plan sponsors."
The Council has urged action on health care price and quality transparency for many years and, in its 2014 long-term strategic plan, A 2020 Vision: Flexibility and the Future of Employee Benefits, specifically called for greater quality and price transparency in the health care system. "Employees should have quality and cost calculators and other tools that provide enrollees with specific data about the quality and total out-of -pocket costs of certain services." Similarly, in written recommendations to the
Additionally, the Council's
* Supports the proposed cost-sharing estimate tool, but urges some changes to mitigate the substantial burdens associated with its development and maintenance, including limiting disclosure to the most common items and service, with phased-in expansions.
* Calls for new rules requiring pre-service disclosures by providers to participants, of the services included in their treatment and the pricing for the services, in acknowledgment of the essential role health care providers play in health care transparency.
* Strongly recommends that plans have two years, rather than one, to implement any final rules, as one year is not realistic even for the most sophisticated employers and issuers.
* Calls for a safe harbor to guard against the potential for increased litigation under ERISA due to the disclosure of negotiated rates, akin to the litigation that has befallen 401(k) plans.
* Supports increased transparency where it is expected to bring down costs, reduce consumer confusion, and result in more value-driven, informed and efficient consumption of health care services.
* Notes that, in certain markets, for some items and services, the public disclosure of negotiated rates could increase competition and potentially lead to lower health care costs, yet, in highly concentrated markets or as a result of anticompetitive behavior, may increase health care cost. Requests that the final rule be structured to avoid the unintended consequence of higher prices resulting from the public disclosure of negotiated rates.
* Strongly supports additional rules with respect to the transparency of health quality, acknowledging that "price is just one piece of the puzzle and, in terms of value, the price of the health care service does not always correlate with the quality of care."
In addition to our support for regulatory efforts to increase transparency to lower health care costs, the Council applauds congressional efforts to do the same. We are particularly supportive of the Lower Health Care Cost Act (S. 1895), approved by the
For more information on the Council's health policy agenda, or to arrange an interview with the Council's health policy team, contact
Rep. Engel Blasts Trump Administration for Playing Politics With Reproductive Health Care During Pandemic
Austria, Italy, Portugal, Spain receive €279m after natural disasters in 2019
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News